Tag: CBT > Cannabis Rescheduling: Page 9

Cannabis Rescheduling

Cannabis Rescheduling Document Details Rationale For Schedule III Recommendation

After multiple FOIA requests and a lawsuit, the U.S. Department of Health & Human Services released more than 250 pages explaining the reasoning for recommending that cannabis be reclassified as a Schedule III drug.

January 12, 2024

Cannabis Rescheduling

DOJ Official Says HHS Will Release Unredacted Cannabis Rescheduling Recommendation Letter

Attorney Matthew Zorn announced that, in response to his FOIA lawsuit, an official confirmed the Department of Health & Human Services would release “the letter and its enclosures in their entirety.”

January 11, 2024

Cannabis Rescheduling

US Congressman Urges DEA to Expedite Rescheduling Cannabis

Rep. Steve Cohen of Tennessee wrote a letter to Administrator Anne Milgram pushing to initiate the rulemaking process “quickly.”

January 5, 2024

Cannabis Rescheduling

Industry Attorney Weighs in on Possible Cannabis Rescheduling Timeline: ‘It Normally Takes Years and Years for This to Get Done’

Despite the U.S. Drug Enforcement Administration’s recent response to a letter from Rep. Earl Blumenauer urging the agency to deschedule cannabis, Porter Wright Morris & Arthur’s Shane Pennington says it could be after the 2024 election before federal officials come to a decision on cannabis’s Schedule I status.

January 4, 2024

Cannabis Rescheduling

President Biden Pardons More Cannabis-Related Convictions, Shortens Sentences of 11 Nonviolent Drug Offenders

The announcement comes as the federal government continues considering whether to reschedule cannabis under the Controlled Substances Act.

January 2, 2024

Alabama

CBT’s Most Popular Articles: December

Here are Cannabis Business Times’ most-viewed stories this month.

December 28, 2023

Florida

5 Cannabis Policy Reform Efforts to Watch in 2024

From the SAFER Banking Act to state-level reform, Akerman’s Jonathan Robbins outlines the legislation and potential policy changes on the horizon for the industry.

December 27, 2023

Cannabis Rescheduling

Former US Attorneys Urge Federal Officials to Reject Cannabis Rescheduling Recommendation

Eric Berlin, partner at Dentons, shares insight into some of the arguments the 29 former attorneys make against removing cannabis from Schedule I of the Controlled Substances Act.

December 21, 2023

Colorado

6 Governors Push Biden to Reschedule Cannabis Before Year’s End

Head executives from Colorado, Illinois, Louisiana, Maryland, New Jersey and New York penned the letter to the White House.

December 6, 2023

Interviews & Opinion

Federal Government Continues to Withhold Key Cannabis Scheduling Recommendation Letter Despite FOIA Requests, Lawsuit

After nearly three months and multiple Freedom of Information Act requests, the U.S. Department of Health and Human Services still has not publicly confirmed that it recommended cannabis be reclassified as a Schedule III controlled substance. One attorney who filed a lawsuit to obtain the letter calls the situation "asinine" and "profoundly disappointing."

November 22, 2023

Cannabis Rescheduling

US Sen. Kirsten Gillibrand Calls on DEA to Reclassify Cannabis as Schedule III

The New York Democrat says cannabis “is simply not comparable to other Schedule I substances like heroin, LSD and MDMA.”

November 21, 2023

Massachusetts

Another Path to Challenge Federal Cannabis Prohibition

Massachusetts cannabis operators and lawyers who filed a lawsuit against the U.S. attorney general over the enforcement of the Controlled Substances Act say they can’t wait—or count on—legislative action for relief.

November 17, 2023